April 18, 2013
Avanir Pharmaceuticals (AVNR)
Updating Estimates – Expecting IP, MS and Alzheimer's Successes
Raising Price Target to $8 from $6
Analyst is projecting breakeven in the December quarter, not including and revs from EU in his estimates.
Sentiment: Strong Buy
Does Wedbush ever say how many years must pass before their 12 month price targets are supposed to hit? Whatever these guys are charging for their service it's way too much. JMHO
Does Wedbush ever state how many years have to pass before the stock is supposed to hit their 12 month target? These guys are shameless (kind of like the Tea Baggers and their zombies in congress, come to think of it). JMHO